Beverage Maker Adopts Health to Wealth Principle With Innovative Launch

From PepsiCo’s innovative push into health-conscious beverages to Charles Schwab’s robust buyback program and First Financial Bancorp’s impressive earnings growth, this roundup highlights key players making strategic moves.

Plus, we cover recent dividend changes, upcoming payouts, and market developments shaping the investment landscape today.

Never Miss a Stock Recommendation Again!

We now send our dividend picks right to your phone via text, so you’ll get the same actionable moves without having to open your inbox.

👉 Click here to get our dividend picks by text and keep our content right at your fingertips.

Upside Guide (Sponsored)

Unlock the Second-Half Strategy

Market volatility, policy shifts, and economic tension are leaving many investors overwhelmed.

But buried under the chaos are clear signals of opportunity — if you know where to look.

That’s why we created a free, exclusive guide highlighting 7 stocks positioned for growth as 2025 progresses.

This report includes:

• Sectors with upside potential through year-end

• Actionable research, not vague predictions

• Key indicators we believe could drive momentum

Even in uncertain times, preparation separates winners from watchers.

Download your copy today and get one step closer to smarter, faster trades.

[Claim your free report now]

Healthcare

Kimberly-Clark Exits IFP Segment in $1.7B Joint Venture With Suzano

Kimberly-Clark (NYSE: KMB) is restructuring its global footprint by forming a $1.7 billion joint venture with Brazilian pulp giant Suzano S.A., which will effectively exit its International Family Care and Professional (IFP) segment. 

Suzano will acquire a controlling 51% stake, while Kimberly-Clark retains 49%. The move signals a shift in focus away from certain emerging-market operations and toward its core personal care and tissue businesses.

For long-term shareholders, this deal suggests a strategic pivot away from lower-margin or complex markets, and toward improved capital allocation and operational clarity. By partnering with Suzano, Kimberly-Clark offloads asset complexity while retaining upside through its minority stake.

Those evaluating a new position in KMB may find this move aligns with a cleaner, more focused corporate structure. The company is signaling discipline in segment management, and this realignment may support stronger margin profiles over time, especially if reinvested capital boosts core brand growth or innovation.

The real test will come in execution, but structurally, Kimberly-Clark is signaling that it’s ready to run leaner, more deliberately, and with sharper geographic discipline. The shift also sets a baseline for investors to track margin improvement and potential reinvestment outcomes as the company adapts its global playbook.

(KMB currently trades at $127 and pays a dividend of $5.04 per share, a yield of 3.98%.)

Retail

Walmart Makes Vizio Exclusive, Pulls Brand from Amazon and Target

Walmart (NYSE: WMT) is turning Vizio into an exclusive in-house brand, removing the popular electronics label from competing retailers like Amazon, Target, and Best Buy. After acquiring Vizio for $2.38 billion in December 2024, Walmart has confirmed that the brand will be sold exclusively through Walmart and Sam’s Club as it integrates Vizio under its expanding private-label strategy.

The rollout is more than a distribution change. Walmart plans to integrate Vizio’s SmartCast software into its broader electronics offerings, including cross-functionality with its Onn brand and a new interface that allows customers to shop directly through their TVs.

For long-term shareholders, this shift reinforces Walmart’s multi-channel strategy and strengthens its digital monetization potential. By pulling Vizio off rival shelves, the company is prioritizing exclusivity and platform control, which are key levers in protecting retail margins and deepening customer stickiness.

Integrating SmartCast could give Walmart a competitive edge in gathering user data and promoting its internal brands. This move would eventually generate advertising revenue through connected TV features.

The Vizio exclusivity push gives Walmart a firmer grip on the fast-growing smart home market. By controlling both the devices and the software layer, Walmart is building a retail ecosystem that reaches far beyond the store aisle.

(WMT currently trades at $97 and pays a dividend of $0.94 per share, a yield of 0.96%.)

Profit Ra (Sponsored)

See the Handpicked 5 Stocks with Major Upside Potential

How would it feel to double your money by this time next year?

From thousands of stocks, only 5 have emerged with the best chance to gain +100% or more in the months ahead.

You can see all five of these tickers — absolutely free.

Just download the newly released 5 Stocks Set to Double special report from Zacks.

While we can’t guarantee future performance, previous editions of this report have delivered gains of +175%, +498%, and even +673¹.

The newest picks could be just as profitable.

Download the report now, absolutely free

*Results may not represent all stock picks and may reflect partially closed positions. Investing involves risk, and past performance does not guarantee future results. This is not financial advice.

Oncology

Pfizer Commits $1.25B to Acquire Global Rights for Next-Gen Cancer Antibody

Pfizer (NYSE: PFE) has expanded its oncology pipeline through a $1.25 billion global licensing agreement with 3SBio, acquiring exclusive rights to the bispecific antibody SSGJ-707 outside of China. The deal also includes a $100 million equity investment and leaves open the option for Pfizer to extend those rights to the Chinese market for an additional $150 million.

SSGJ-707 targets PD-1 and VEGF, two critical pathways in cancer treatment, and has already shown promising Phase II results in China for non-small cell lung cancer. Pfizer will manufacture the drug substance in North Carolina and oversee global clinical development, including new trials conducted across the U.S. and at other international sites, with a focus on solid tumors.

For long-term shareholders, the agreement strengthens Pfizer's positioning in next-generation immuno-oncology therapies. Rather than relying solely on in-house R&D, the company is leveraging external innovation to fill pipeline gaps in high-impact cancer indications.

Those looking into Pfizer should see this deal as more than portfolio padding. It aligns with a broader capital deployment strategy that prioritizes scalable cancer treatments with multi-market potential. The planned Phase III development path also aligns with Pfizer's shift toward specialized therapeutics beyond traditional blockbusters.

SSGJ-707 provides Pfizer with a fresh asset, boasting global ambitions, early clinical momentum, and room to build combination strategies. As trial results emerge, this could become a foundational component in the company's oncology expansion.

(PFE currently trades at $25 and pays a dividend of $1.72 per share, a yield of 6.96%.)

AROC has increased its quarterly dividend payment to 21 cents per share, an increase of 10.53%. Its new yield is 3.59%. 

FIX has raised its quarterly dividend payment to 50 cents per share, an increase of 11.11%. Its new yield is 0.36%. 

Southern Missouri Bancorp raised its dividend payment to 25 cents per share, an increase of 8.70%. Its new yield is 1.6%.

DMLP has decreased its dividend payment to 62 cents per share, a drop of 14.55%. The new yield is 9.03%. 

TIMB has reduced its dividend payment to 12 cents per share, a cut of 14.67%. Its new yield is 7.2%. 

DOW has slashed its dividend payout to 35 cents per share, a decline of 50%. The yield is now 4.6%.

Upside (Sponsored)

This AI Shift Is Creating Quiet Winners

The escalating U.S.-China trade tensions are reshaping the AI landscape.

Companies like Nvidia are facing significant revenue hits with the U.S. imposing new export restrictions on advanced AI chips to China.

This shift opens doors for U.S.-based AI companies poised to fill the gap. I’ve identified 9 under-the-radar AI stocks with:

1. Deep AI integration across their core operations

2. Strong U.S. manufacturing capabilities

3. Proven revenue growth from AI initiatives

4. Infrastructure ready to capitalize on policy shifts

Access our FREE report, "Top 9 AI Stocks for This Month" to discover these opportunities before the broader market catches on.

Everything Else

• After months of scrutiny, the F.C.C. has finally given the greenlight for an $8 billion merger which will unite Paramount with the Hollywood studio, Skydance.

  As the tech industry grapples with a new round of layoffs, Microsoft CEO Satya Nadella says the job losses are weighing heavy – even as a new round of cuts pushes MSFT above $500 for the first time.

  Delta Airlines have been asked to explain plans to use AI technology to help set ticket prices, with senators concerned it may push up prices.

  Blackstone has set a new industry record after it revealed its total assets under management now top $1.2 trillion.

  Ryder System has revealed a surprising uptick in sales in one area of its business that is often overlooked: used tractor prices are up by 3%.